Provided by Tiger Fintech (Singapore) Pte. Ltd.

Orchestra BioMed

4.08
+0.24006.25%
Post-market: 4.080.00000.00%16:23 EDT
Volume:43.60K
Turnover:175.43K
Market Cap:155.10M
PE:-2.55
High:4.13
Open:3.93
Low:3.88
Close:3.84
Loading ...

Orchestra BioMed initiated with an Overweight at Barclays

TIPRANKS
·
02 Jan

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds

Simply Wall St.
·
25 Dec 2024

Orchestra BioMed announces AVIM therapy program presentations

TIPRANKS
·
09 Dec 2024

Orchestra Biomed Announces Avim Therapy Program Presentations at Ici Meeting

THOMSON REUTERS
·
09 Dec 2024

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

GlobeNewswire
·
09 Dec 2024

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire
·
27 Nov 2024

Orchestra BioMed Holdings Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024

Orchestra BioMed’s Strong Financial Performance and Strategic Developments Reinforce Buy Rating with $14 Price Target

TIPRANKS
·
14 Nov 2024

Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
14 Nov 2024

We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully

Simply Wall St.
·
14 Nov 2024

Orchestra BioMed Holdings: Strategic Financial Developments and Clinical Progress Justify Buy Rating

TIPRANKS
·
13 Nov 2024

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
13 Nov 2024

Orchestra BioMed Hldgs Q3 2024 GAAP EPS $(0.41) Beats $(0.43) Estimate, Sales $987.00K Beat $711.50K Estimate

Benzinga
·
13 Nov 2024

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire
·
13 Nov 2024

Sidoti Events, LLC's Virtual November Micro-Cap Conference

ACCESSWIRE
·
12 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Nov 2024